Skip to main content

Advertisement

Log in

Saikosaponin-D Prevents Acute Renal Injury via Inhibition of NLRP3 Inflammasome By SIRT1

  • SEARCH FOR NEW DRUGS
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The chemical composition of bupleurum plant is complex. The main active components of bupleurum are saponins, volatile oils, flavonoids and polysaccharides, exerting multiple pharmacological effects. Here, we have first found that saikosaponin-d (SSD) reduced kidney injury and inflammation, induced SIRT1, and suppressed protein expression on in vivo mice model of acute kidney injury (AKI). In LPS-induced kidney cell inflammation model, SSD suppressed IL-1B, NLRP3, SIRT1 and ROS expression as detected after cells were treated with SSD. Furthermore, the anti-inflammation effects of SSD on inflammation and kidney injury were detected on in vivo mice model of ARI via NLRP3 expression. The results showed that ROS inhibitor increased anti-inflammation effects of SSD on in vivo mice inflammation model and in vitro model. Finally, NLRP3 inhibitor also reduced anti-inflammation effects of SSD on in vivo mice inflammation model and in vitro model. On the whole, these findings confirm that SSD prevents AKI via inhibition of NLRP3 inflammasome by SIRT1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.

Similar content being viewed by others

References

  1. A. Ghaemian, J. Yazdani, S. Azizi, et al. BMC Nephrol., 19, 373 (2018).

    Article  CAS  Google Scholar 

  2. Y.Wang, Y. Shi, X. Xu, et al., Medicine (Baltimore), 98, e16049 (2019).

    Article  Google Scholar 

  3. Y. Yao, X. Hu, X. Feng, et al.. J. Cell Biochem., 120, 18509 – 18523 (2019).

    Article  CAS  Google Scholar 

  4. T. Liu, L. Tang, H. Tang, et al.. Front. Immunol., 10, 1925 (2019).

    Article  CAS  Google Scholar 

  5. A. A. Shigeoka, J. L. Mueller, A. Kambo, et al., J. Immunol., 185, 6277 – 6285 (2010).

    Article  CAS  Google Scholar 

  6. S. Wang, J. Fan, X. Mei, et al., Front. Immunol., 10, 2277 (2019).

    Article  CAS  Google Scholar 

  7. Y. D. Tian, S. Lin, P. T. Yang, et al., J. Cancer., 10, 4947 – 4953 (2019).

    Article  CAS  Google Scholar 

  8. M. Ren, E. McGowan, Y. Li, et al. Front. Pharmacol., 10, 623 (2019).

    Article  CAS  Google Scholar 

  9. C. Y. Zhang, Z. M. Jiang, X. F. Ma, et al., Front. Pharmacol., 10, 1039 (2019).

    Article  CAS  Google Scholar 

  10. M. Antonic, Heart Surg. Forum, 20, E214-E218 (2017).

    Article  Google Scholar 

  11. X. Wu, Z. Jiang, J. Ying, et al., J. Clin. Anesth., 43, 77 – 83 (2017).

    Article  Google Scholar 

  12. H.W.Wang, M. Liu, T. D. Zhong, et al., Int. J. Clin. Exp. Med., 8, 15137 – 15145 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. X. Li, Q.Wang, G. Deng, et al., Toxicol. Appl. Pharmacol., 380, 114704 (2019).

    Article  CAS  Google Scholar 

  14. Q. Gao and H. Zhu, Med. Sci. Monit., 25, 2718 – 2726 (2019).

    Article  CAS  Google Scholar 

  15. K. Li, T. X. Liu, J. F. Li, et al., Biochem. Biophys. Res. Commun., 517, 557 – 565 (2019).

    Article  CAS  Google Scholar 

  16. S. Shi, S. Lei, C. Tang, et al., Biosci. Rep., 39 (2019).

  17. R. Que, Y. Shen, J. Ren, et al., Int. J. Mol. Med., 41, 1357 – 1364 (2018).

    CAS  PubMed  Google Scholar 

  18. S. M. Kim, Y. G. Kim, D. J. Kim, et al., Front. Immunol., 9, 2563 (2018).

    Article  Google Scholar 

  19. X. Qu, H. Gao, L. Tao, et al., J. Biochem. Mol. Toxicol., e22208 (2018).

  20. Z. Pu, C. Han, W. Zhang, et al., Am. J. Transl. Res., 11, 3992 – 4009 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

All animal procedures in this study were approved by the Institutional Animal Care and Use Committee of the Hebei General Hospital

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

Lin Kang was dedicated to the integrity of the entire study; Fan Yang carried out the study concepts, definition of intellectual content, data acquisition and manuscript editing; Xiuzhi Zhang was involved in the manuscript preparation; Jing Zhao focused on the experimental studies; Yang Liu carried out the statistical analysis; Huanfen Zhao was involved in the manuscript review; Zhijuan Hu focused on the clinical studies and data analysis; Bing Liu was dedicated to the study design; Chunnian He carried out the literature research. All authors have read and approved this article.

Corresponding author

Correspondence to Huanfen Zhao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, L., Yang, F., Zhang, X. et al. Saikosaponin-D Prevents Acute Renal Injury via Inhibition of NLRP3 Inflammasome By SIRT1. Pharm Chem J 55, 1169–1176 (2022). https://doi.org/10.1007/s11094-022-02554-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02554-w

Keywords

Navigation